Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 5 institutions in 2 countries.
Hishar HassanCentre for Diagnostic Nuclear Imaging, Universiti Putra Malaysia (UPM), Serdang 43400, Malaysia.ORCID 0000-0001-5167-8063
Muhamad Faiz OthmanDepartment of Pharmacy Practice, Faculty of Pharmacy, Universiti Teknologi MARA, Bandar Puncak Alam 42300, Malaysia.ORCID 0000-0002-9024-4548
Hairil Rashmizal Abdul RazakMedical Imaging Program, Department of Health and Care Professions, Faculty of Health and Life Sciences, St Luke's Campus, University of Exeter, Devon EX1 2LU, UK.ORCID 0000-0002-8266-0381
Zainul Amiruddin ZakariaBorneo Research on Algesia, Inflammation and Neurodegeneration (BRAIN) Group, Department of Biomedicine, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu 88400, Malaysia.ORCID 0000-0001-5525-7821
Fathinul Fikri Ahmad SaadCentre for Diagnostic Nuclear Imaging, Universiti Putra Malaysia (UPM), Serdang 43400, Malaysia.ORCID 0000-0002-0499-7747
Mohd Azuraidi OsmanDepartment of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia (UPM), Serdang 43400, Malaysia.
Loh Hui YiDepartment of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia (UPM), Serdang 43400, Malaysia.
Zarif AshharDepartment of Nuclear Medicine, National Cancer Institute, Putrajaya 62250, Malaysia.ORCID 0000-0001-5057-4705
Jaleezah IdrisDepartment of Nuclear Medicine, National Cancer Institute, Putrajaya 62250, Malaysia.
Mohd Hamdi Noor Abdul HamidDepartment of Nuclear Medicine, National Cancer Institute, Putrajaya 62250, Malaysia.
Zaitulhusna M SafeeDepartment of Nuclear Medicine, National Cancer Institute, Putrajaya 62250, Malaysia.
National Cancer Institute · MYUniversiti Putra Malaysia · MYUniversiti of Malaysia Sabah · MYUniversiti Teknologi MARA · MYUniversity of Exeter · GB
Funding
Universiti Putra Malaysia Putra Grant - 9580700Universiti Teknologi MARA MyRA LPhD - 600-RMC/GPM LPHD 812 5/3
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Preparation, Optimisation, and In Vitro Evaluation of [ · full record | OpenQuestion